quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:14:38·532d
SECFiling
Viad Corp logo

SEC Form 10-Q filed by Viad Corp

VVI· Viad Corp
Consumer Discretionary
Full content unavailable. See the original source below.
Original source

Companies

  • VVI
    Viad Corp
    Consumer Discretionary

Recent analyst ratings

  • Jun 28UpdateCraig Hallum$40.00
  • Jun 14UpdateOppenheimer$42.00
  • Mar 7UpdateB. Riley Securities$51.00
  • Feb 11UpdateSidoti$42.00

Related

  • NEWS260d
    Valiant Eagle Inc. (OTC:PSRU) Subsidiary, Providence Film Group Cements Unmatched Legal Control of 12 Iconic Films With Copyright Recordation, Charting Path to Explosive Shareholder Value
  • SEC471d
    Viad Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
  • INSIDER475d
    President and CEO Barry David W was granted 21,619 shares, increasing direct ownership by 24% to 109,937 units (SEC Form 4)
  • INSIDER475d
    CHIEF FINANCIAL OFFICER Ingersoll Ellen M covered exercise/tax liability with 4,484 shares, decreasing direct ownership by 17% to 22,677 units (SEC Form 4)
  • INSIDER475d
    Chief Executive Officer Moster Steven W covered exercise/tax liability with 17,016 shares, decreasing direct ownership by 16% to 89,712 units (SEC Form 4)
  • PR478d
    Truelink Capital and Viad Close Transaction to Establish GES as Independent Business
  • INSIDER478d
    Director Crestview Partners Iv Gp, L.P. converted options into 6,674,234 shares (SEC Form 4)
  • SEC478d
    Viad Corp filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022